Company / Depreciation & Amortization
Vericel Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$11.5M
FY2025
5-year range
$1.7M / $11.5M
FY2021-FY2025
Trend
+109.7%
vs FY2024
Sector context
#60 of 168
Health Care
What the data says
At $12M, Vericel's depreciation & amortization ranks #109 of 168 in the Health Care sector. Depreciation & Amortization has increased for 5 consecutive years, from $1M in FY2020 to $12M in FY2025.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +51.9%.
Increased from $5M to $12M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +69.2%
- 5-Year CAGR
- +51.9%
- 10-Year CAGR
- -
Sector benchmark
#109 of 168 in Health CareTop 64% of 168This company $11.5M Sector average $212.9M
▼
-94.6% below sector average
Key checks
Key Insights
- Vericel's depreciation & amortization has grown for 5 consecutive years.
- 5-year CAGR of +51.9%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 109.7% year-over-year.
- Ranks #60 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.5M | +109.7% |
| FY2024 | $5.5M | +18.8% |
| FY2023 | $4.6M | +94.4% |
| FY2022 | $2.4M | +40.2% |
| FY2021 | $1.7M | +19.2% |
| FY2020 | $1.4M | -11.5% |
| FY2019 | $1.6M | -14.5% |
| FY2018 | $1.9M | +18.5% |
| FY2017 | $1.6M | +111.7% |
| FY2016 | $752.0K | +53.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026